Calcineurin Inhibitors
Showing 51 - 75 of 4,527
Dermatitis, Atopic, Pruritus Trial in United States (ASN008, ASN008 Matching Vehicle)
Recruiting
- Dermatitis, Atopic
- Pruritus
- ASN008
- ASN008 Matching Vehicle
-
Scottsdale, Arizona
- +17 more
May 24, 2023
Kidney Transplant, Immunosuppression, Allograft Trial (KidneyCare, steroid, MMF)
Not yet recruiting
- Kidney Transplant
- +2 more
- KidneyCare
- +2 more
- (no location specified)
Jun 22, 2022
or Complications of Kidney, Immune or Transplantation-related
Recruiting
- Acute Kidney Injury
- +5 more
- Biological samples collection
-
Toulouse, FranceRangueil University Hospital
Dec 6, 2022
Chronic Kidney Failure Trial in Nantes (Belatacept 250 Milligram Intravenous Powder for Solution)
Not yet recruiting
- Chronic Kidney Failure
- Belatacept 250 Milligram Intravenous Powder for Solution
-
Nantes, Loire Atlantique, FranceCHU Nantes
Sep 28, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Le Kremlin-Bicêtre (Everolimus, Calcineurin inhibitors maintenance)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Everolimus
- Calcineurin inhibitors maintenance
-
Le Kremlin-Bicêtre, FranceBicêtre Hospital
Dec 7, 2018
Liver Transplant, Kidney Transplant Trial in Los Angeles, Gainesville, Singapore (PPM-based Computation Assisted Drug Dosing,
Completed
- Liver Transplant
- Kidney Transplant
- PPM-based Computation Assisted Drug Dosing
- Tacrolimus
-
Los Angeles, California
- +2 more
Dec 9, 2021
Long-term Outcomes After Conversion to Belatacept
Unknown status
- Kidney Transplant Failure and Rejection
- +3 more
- Conversion to a belatacept regimen
- (no location specified)
Jan 29, 2021
Kidney Transplant; Complications, Toxicity, Drug Toxicity Trial in Sacramento (Envarsus, IR Tacrolimus)
Recruiting
- Kidney Transplant; Complications
- +3 more
- Envarsus
- IR Tacrolimus
-
Sacramento, CaliforniaUC Davis
Jan 25, 2022
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
First Manifestation of Steroid Sensitive Nephrotic Syndrome Trial in Paris (Levamisole Hydrochloride, Placebo)
Completed
- First Manifestation of Steroid Sensitive Nephrotic Syndrome
- Levamisole Hydrochloride
- Placebo
-
Paris, FranceHôpital Robert Debré
Jun 7, 2022
Posttransplant Diabetes Trial in Tuebingen (LCP-tacrolimus, twice-daily tacrolimus)
Recruiting
- Posttransplant Diabetes Mellitus
- LCP-tacrolimus
- twice-daily tacrolimus
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Jun 21, 2022
Atopic Dermatitis Trial in Worldwide (ZPL389 30mg, ZPL389 50mg, TCS and/or TCI)
Terminated
- Atopic Dermatitis
- ZPL389 30mg
- +2 more
-
Litchfield Park, Arizona
- +47 more
Oct 7, 2021
Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)
Active, not recruiting
- Chronic Graft-versus-host-disease
-
Birmingham, Alabama
- +10 more
Aug 18, 2022
Efficacy Trial in Beijing (Prednisone, ciclosporin and mycophenolate mofetil, Ponticelli Regimen)
Completed
- Efficacy
- Prednisone, ciclosporin and mycophenolate mofetil
- Ponticelli Regimen
-
Beijing, Beijing, China
- +1 more
Feb 2, 2022
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
Rituximab for Refractory or Relapsed Focal Segmental
Completed
- Focal Segmental Glomerulosclerosis
- Minimal Change Disease
-
Istanbul, TurkeyIstanbul University
Nov 28, 2020
Atopic Dermatitis, Atopic Eczema Trial in Hellerup (Betnovate, betamethasone dipropionate ointment 0.1% and , Protopic,
Completed
- Atopic Dermatitis
- Atopic Eczema
- Betnovate, betamethasone dipropionate ointment 0.1% and placebo
- Protopic, tacrolimus ointment 0.1%
-
Hellerup, Region Hovedstaden, DenmarkDepartment of Dermatology and Allergy
Apr 27, 2021
GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))
Not yet recruiting
- Graft Versus Host Disease
- Allogeneic mesenchymal stromal cells (MSCs)
- Extracorporeal photopheresis (ECP)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022
Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)
Not yet recruiting
- Heart Transplant
- +2 more
- HeartCare
- (no location specified)
Jul 12, 2022
Kidney Transplantation, Cytomegalovirus Infections Trial in L'Hospitalet de Llobregat (Switch from Mycophenolate Mofetil to
Not yet recruiting
- Kidney Transplantation
- Cytomegalovirus Infections
- Switch from Mycophenolate Mofetil to Everolimus manteinance treatment in Active Comparator Arm
- no intervention
-
L'Hospitalet de Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Jun 16, 2021
Kidney Transplantation Trial in Buffalo (Kidney Biopsy, Rapamune (sirolimus/rapamycin), Tacrolimus)
Completed
- Kidney Transplantation
- Kidney Biopsy
- +2 more
-
Buffalo, New YorkBuffalo General Hospital Multi-Organ Transplant Department
Nov 4, 2020
Port Wine Stain Trial (Topical Antiangiogenic, Pulsed Dye Laser)
Withdrawn
- Port Wine Stain
- Topical Antiangiogenic
- Pulsed Dye Laser
- (no location specified)
Oct 28, 2022
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022